Cyclacel Pharmaceuticals presented the efficacy of fadraciclib in a patient-derived colorectal cancer model at the 2024 ASCO Annual Meeting.
Cyclacel Pharmaceuticals：Fadraciclib在2024年ASCO年会上展示了在患者源性结直肠癌模型中的功效。
Cyclacel Pharmaceuticals presented the efficacy of fadraciclib in a patient-derived colorectal cancer model at the 2024 ASCO Annual Meeting.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.